Profil
Dan Parry is currently the Chief Financial Officer at Hydrexia Pty Ltd. Prior to this, he was the Chief Financial & Operating Officer at Oventus Medical Ltd. from 2017 to 2021.
Before that, he worked as the Chief Financial Officer & Secretary at Implicit Bioscience Ltd. from 2005 to 2013.
Mr. Parry holds an MBA from Kellogg School of Management.
Postes actifs de Dan Parry
| Sociétés | Poste | Début |
|---|---|---|
Hydrexia Pty Ltd.
Hydrexia Pty Ltd. Information Technology ServicesTechnology Services Provides hydrogen energy technology solutions | Directeur Financier/CFO | 01/09/2013 |
Anciens postes connus de Dan Parry
| Sociétés | Poste | Fin |
|---|---|---|
| OVES MEDI | Directeur Financier/CFO | 04/06/2021 |
Implicit Bioscience Ltd.
Implicit Bioscience Ltd. BiotechnologyHealth Technology Operates as a clinical-stage immunotherapy drug development company | Directeur Financier/CFO | 01/01/2013 |
Formation de Dan Parry
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Hydrexia Pty Ltd.
Hydrexia Pty Ltd. Information Technology ServicesTechnology Services Provides hydrogen energy technology solutions | Technology Services |
Implicit Bioscience Ltd.
Implicit Bioscience Ltd. BiotechnologyHealth Technology Operates as a clinical-stage immunotherapy drug development company | Health Technology |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oventus Medical Ltd.
Oventus Medical Ltd. Medical SpecialtiesHealth Technology Develops oral appliances for the treatment of obstructive sleep disordered and snoring | Health Technology |
















